Previous 10 | Next 10 |
Laboratory Corporation of America (NYSE:LH) has entered into an agreement to acquire Personal Genome Diagnostics (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products. Under the terms of the agreement, Labcorp will pay $450M in cash...
Broader Access to Innovative Diagnostics Improves Patient Outcomes and Accelerates Clinical Trials Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Personal Genome Diagnostics Inc. ( ...
Wallace Weitz's 13F portfolio value increased from $2.37B to $2.39B this quarter. The number of positions decreased from 60 to 58. Weitz Investment Management increased Dun & Bradstreet Holdings during the quarter. The top three positions are Alphabet, Berkshire Hathaway, and ...
As COVID cases are surging and along with it a resurgence in the demand for testing, test makers are mixed so far today. Quidel (QDEL -5.8%), a largest manufacturers of at-home tests, is the worst performer of the group. OraSure Technologies (OSUR -3.1%), another at-home test maker, is also d...
Halvorsen's 13F portfolio value increased from $32.98B to $36.04B this quarter. The number of positions increased from 88 to 96. Viking Global added McDonald’s and increased General Electric, Humana, Brookfield Asset Management, and Parker Hannifin while dropping Aon plc during...
For 2022, I am going to focus on those companies poised to benefit from the tragic COVID-19 pandemic. I maintain that SARS-CoV-2 will be with us for a long time. As for the proposed drug price legislation in BBBA, it would impact biologics (high cost medications) only near the end of ...
Laboratory Corporation (LH -4.0%) to initiate dividend in Q2 2022, targeting a dividend payout ratio of between 15-20% of adjusted earnings. Company also authorizes a $2.5B share repurchase program. As part of this program, $1B will be repurchased under an accelerated share repurchase pl...
Board of Directors Approves Plans to Initiate Quarterly Cash Dividend and Authorizes $2.5 Billion Share Repurchase Program Capital Allocation Plan Enables Continued Investments in Key Growth Areas, Science and Innovation Labcorp (NYSE: LH) (the Company), a leadin...
Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Toxikon Corporation, a contract research organization delivering best-in-class nonclinical testing services. The addition of Toxikon to Labcorp Drug Development bolsters...
Point Roberts, WA and Vancouver, BC - December 2, 2021 (Investorideas.com Newswire) Investorideas.com ( www.investorideas.com ), a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye - watching stock news, deal tracker and advan...
News, Short Squeeze, Breakout and More Instantly...
Laboratory Corporation of America Holdings Company Name:
LH Stock Symbol:
NYSE Market:
Laboratory Corporation of America Holdings Website:
Labcorp to Announce Second Quarter Financial Results on August 1, 2024 PR Newswire BURLINGTON, N.C. , July 1, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for ...
2024-06-19 01:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Labcorp Launches Global Trial Connect to Accelerate Clinical Trials PR Newswire Suite of digital and data solutions designed to improve clinical trial efficiency, reduce data delays and simplify investigator site workflows BURLINGTON, N.C. , June 17, 2024 /PR...